Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways
Best Price:
Buy Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways for $129.00 at @ Link.springer.com
No coupon is required — this is the standard retail price.
0 Reviews
Set a price drop alert to never miss an offer.
1 Offer
Price Range: $129.00 - $129.00
Price Comparison
| Seller | Contact Seller | List Price | On Sale | Shipping | Best Promo | Final Price | Volume Discount | Financing | Availability | Seller's Page |
|---|---|---|---|---|---|---|---|---|---|---|
|
BEST PRICE 1 Product Purchase
|
|
$129.00 | $129.00 |
|
$129.00 | See Site | In stock | Visit Store |
Product Details
Brand
Springer Nature
Manufacturer
N/A
Part Number
0
GTIN
9783319679303
Condition
New
Product Description
This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression. Each chapter will cover a specific group of targets and the cognate drugs, along with molecular modes of innate and evolving resistance.
Available Colors
Available Sizes

